Lymphokine-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicity

This publication has 21 references indexed in Scilit:

• Use of millipore diffusion chambers to assay in vivo IL-2 activity
  Journal of Immunological Methods, 1985
• Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
  The Journal of Experimental Medicine, 1984
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Structural homology of a macrophage differentiation antigen and an antigen involved in T-cell-mediated killing
  Nature, 1982
• Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes
  Nature, 1981
• Structural characterization of the ‘melanoma-specific’ antigen detected by monoclonal antibody 691I5Nu-4-B
  Molecular Immunology, 1981
• Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt‐2 locus
  European Journal of Immunology, 1980
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes
  European Journal of Immunology, 1973
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970